Care este prețul pentru MultiCell Technologies, Inc. (MCET)

Prețul pentru MultiCell Technologies, Inc. (MCET) este $0.00001

Care este capitalizarea de piață pentru MultiCell Technologies, Inc. (MCET)

Capitalizarea de piață pentru MultiCell Technologies, Inc. (MCET) este $50.01K

MultiCell Technologies, Inc. (MCET) Splituri de Acțiuni

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

An	Split	Multiplu	Multiplu cumulativ
2005-05-20	1:5	x0.2	x0.0212
1992-12-01	1:10	x0.1	x0.106
1992-11-23	53:50	x1.06	x1.06

Split

Multiplu

Multiplu cumulativ

2005-05-20

1:5

x0.2

x0.0212

1992-12-01

1:10

x0.1

x0.106

1992-11-23

53:50

x1.06

Companie	Număr total de splituri	Multiplu cumulativ	Țara
Novo Nordisk A/S NVO.US	5	x199	DK
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Regeneron Pharmaceuticals, Inc. REGN.US	0	-	US
UCB SA UCB.BR	0	-	BE
CSL Limited CSL.AX	1	x3	AU

Companie

Număr total de splituri

Multiplu cumulativ

Țara